Metformin-d6

Metformin-d6 (1,1-Dimethylbiguanide-d6) serves as a stable isotope-labeled version of Metformin, which primarily targets the mitochondrial respiratory chain in the liver. This compound is critical for studies on type 2 diabetes management due to its role in activating AMPK, thus enhancing insulin sensitivity. Additionally, Metformin-d6 contributes to understanding glucose regulation through the inhibition of Rap1 in SF1 hypothalamic neurons. Its utility extends to investigating liver oxidative stress and the modulation of autophagy-related proteins via AMPK activation and mTOR inhibition, making it relevant for evaluating renal cell carcinoma growth in both in vitro and in vivo settings.